Hyoscine Market by Type (Hyoscine Butylbromide and Hyoscine Hydrobromide) and Application (Oral, Injections, and Patches) - Global Opportunity Analysis and Industry Forecast, 2020-2027
|
A03048
|
Pages: NA
|
Oct 2020 |
2427 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Hyoscine Market
Request Now !Hyoscine, also referred as scopolamine, is utilized as a medicine to treat motion sickness, gastrointestinal spasms, vomiting, and postoperative nausea. In addition, it is utilized sometimes before surgery to decrease saliva. Hyoscine belongs to antimuscarinic family and works by blocking some acetylcholine effects within the nervous system. Its effect begins after 20 minutes of injection and lasts up to 8 hours. The medicine can be taken by oral means or through a skin patch. Intake of this medicine is not recommended for people suffering from bowel obstruction or glaucoma.
Rise in consumer awareness towards hyoscine as an effective medicine against motion sickness is the primary factor that drive the growth of the hyoscine market. Moreover, increase in travelling, which may cause nausea, vomiting, and sickness and growth in number of surgeries supplement the market growth. However, use of transdermal hyoscine patches can cause several side effects such as blurred vision, drowsiness, and diluted pupils, which hinder the market growth. In addition, stringent regulations associated with manufacturing & marketing of hyoscine products and rise in number of cases with adverse withdrawal symptoms for transdermal hyoscine patches restrain the market growth. Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery and rise in emphasis on community healthcare in developing countries are expected to provide potential opportunities for market expansion.
The report segments the hyoscine market on the basis of type, application, and geography. Based on type, the market is divided into hyoscine butylbromide and hyoscine hydrobromide. By application, it is categorized into oral, injections, and patches. Geographical breakdown of the market includes North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive Competitive Analysis And Profiles Of Major Market Players Provided In The Report Are As Follows:
- Alchem International Ltd.
- Alkaloids Corporation
- Baxter International Inc.
- Caleb Pharmaceuticals, Inc.
- Centroflora Cms S. R.L.
- GlaxoSmithKline Plc
- Guangzhou Hanfang Pharmaceutical Co., Ltd.
- Myungmoon Pharma Co., Ltd.
- Novartis International AG
- Perrigo Company Plc
Key Benefits
- This report provides a quantitative analysis of the current trends and estimations from 2017 to 2023 of the global hyoscine market to identify the prevailing market opportunities.
- Major countries in each region are mapped according to individual market revenue.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- An in-depth analysis of current research & clinical developments within the market is provided with key dynamic factors.
- Key players and their key developments in the recent years are listed.
Hyoscine Market Segments:
By Type
- Hyoscine Butylbromide
- Hyoscine Hydrobromide
By Application
- Oral
- Injections
- Patches
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 GLOBAL HYOSCINE MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Key growth factors and opportunities
4.1.3. Market size and forecast
4.2. HYOSCINE BUTYLBROMIDE
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. HYOSCINE HYDROBROMIDE
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 GLOBAL HYOSCINE MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ORAL
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.3. INJECTIONS
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.4. PATCHES
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
CHAPTER 6 GLOBAL HYOSCINE MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. By Type
6.2.3.2. By Application
6.2.4. U.S.
6.2.4.1. Market size and forecast, by Application
6.2.5. Canada
6.2.5.1. Market size and forecast, by Application
6.2.6. Mexico
6.2.6.1. Market size and forecast, by Application
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. By Type
6.3.3.2. By Application
6.3.4. UK
6.3.4.1. Market size and forecast, by Application
6.3.5. Germany
6.3.5.1. Market size and forecast, by Application
6.3.6. France
6.3.6.1. Market size and forecast, by Application
6.3.7. Spain
6.3.7.1. Market size and forecast, by Application
6.3.8. Italy
6.3.8.1. Market size and forecast, by Application
6.3.9. Rest of Europe
6.3.9.1. Market size and forecast, by Application
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. By Type
6.4.3.2. By Application
6.4.4. China
6.4.4.1. Market size and forecast, by Application
6.4.5. Japan
6.4.5.1. Market size and forecast, by Application
6.4.6. India
6.4.6.1. Market size and forecast, by Application
6.4.7. Australia
6.4.7.1. Market size and forecast, by Application
6.4.8. South Korea
6.4.8.1. Market size and forecast, by Application
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. By Type
6.5.3.2. By Application
6.5.4. Brazil
6.5.4.1. Market size and forecast, by Application
6.5.5. South Africa
6.5.5.1. Market size and forecast, by Application
6.5.6. Saudi Arabia
6.5.6.1. Market size and forecast, by Application
6.5.7. Rest of LAMEA
6.5.7.1. Market size and forecast, by Application
CHAPTER 7 COMPANY PROFILES
7.1. ALCHEM INTERNATIONAL LTD.
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. ALKALOIDS CORPORATION
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. BAXTER INTERNATIONAL INC.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. CALEB PHARMACEUTICALS, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. CENTROFLORA CMS S.À R.L.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. GLAXOSMITHKLINE PLC
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. GUANGZHOU HANFANG PHARMACEUTICAL CO., LTD.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. MYUNGMOON PHARMA CO., LTD.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. NOVARTIS INTERNATIONAL AG
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. PERRIGO COMPANY PLC
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Hyoscine Market- Global Opportunity Analysis and Industry Forecast, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Â T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.